MASS (908 Devices) EBIT: $-23.65 Mil (TTM As of Mar. 2026)


MASS 908 Devices Inc MASS
70 GF Score
Price $8.98
GF Value $6.91
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is 908 Devices EBIT?

908 Devices MASS +2.87% 70 EBIT is $-23.65 Mil as of Mar. 2026. GuruFocus rates MASS with a GF Score™ of 70/100 and a GF Value™ of $6.91 (Modestly Overvalued). The stock has 9 warning signs investors should review.

908 Devices's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $-6.50 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-23.65 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. 908 Devices's annualized ROC % for the quarter that ended in Mar. 2026 was -33.94%. 908 Devices's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -169.50%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. 908 Devices's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -10.20%.

908 Devices  (NAS:MASS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

908 Devices's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-26.012 * ( 1 - 0% )/( (76.029 + 77.257)/ 2 )
=-26.012/76.643
=-33.94 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=190.071 - 3.547 - ( 112.97 - max(0, 34.064 - 144.559+112.97))
=76.029

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=186.695 - 7.084 - ( 111.742 - max(0, 39.66 - 142.014+111.742))
=77.257

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

908 Devices's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-26.012/( ( (8.629 + max(-1.794, 0)) + (8.346 + max(13.718, 0)) )/ 2 )
=-26.012/( ( 8.629 + 22.064 )/ 2 )
=-26.012/15.3465
=-169.50 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(11.327 + 12.99 + 7.272) - (3.547 + 8.934 + 20.902)
=-1.794

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(9.865 + 13.24 + 7.167) - (7.084 + 9.47 + -7.105427357601E-15)
=13.718

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

908 Devices's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-23.654/231.913
=-10.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

908 Devices EBIT Related Terms

908 Devices EBIT Historical Data

* Premium members only.

The historical data trend for 908 Devices's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

908 Devices EBIT Chart

908 Devices Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial -21.68 -33.43 -36.41 -29.95 -25.68

908 Devices Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.53 -8.37 -5.62 -3.17 -6.50

MASS vs ELMD, SI, CV: EBIT Comparison

For the Medical Devices subindustry, 908 Devices's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

908 Devices EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where 908 Devices's EV-to-EBIT falls into.


MASS
70GF Score
908 Devices Inc MASS
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

908 Devices EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-23.65 Mil mean?
908 Devices (MASS) has a EBIT of $-23.65 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on 908 Devices.
Is 908 Devices' EBIT too high?
908 Devices' current EBIT is $-23.65 Mil. Overall, 908 Devices has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 908 Devices' EBIT compare to ELMD and SI?
908 Devices' EBIT of $-23.65 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on 908 Devices. 908 Devices's current EBIT is $-23.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 908 Devices stock overvalued right now?
Based on GuruFocus' analysis, 908 Devices (MASS) is currently considered Modestly Overvalued. The stock's GF Value™ is $6.91, compared to a current price of $8.98 — trading 30% above its estimated fair value. The current EBIT is $-23.65 Mil. 908 Devices' overall GF Score™ is 70/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For 908 Devices (MASS), the current EBIT is $-23.65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 908 Devices (MASS) Overvalued in 2026?

Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued. The current stock price of $8.98 is trading 30% above its estimated GF Value™ of $6.91. GuruFocus considers 908 Devices to be Modestly Overvalued.

Key valuation signals for MASS:

  • EBIT: $-23.65 Mil
  • GF Value™: $6.91 vs. price of $8.98 (30% above fair value)
  • GF Score™: 70/100 with 9 warning signs

No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

908 Devices Business Description

Address 44 3rd Avenue, Burlington, MA, USA, 01803
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
70GF Score

Get the complete analysis for MASS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.98
Price
$6.91
GF Value